Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Multicentre Hospital-based Case-control Study of Diffuse Large B-cell Lymphoma in Shanghai, China

  • Fan, Rong (Department of Hematology, Huashan Hospital of Fudan University) ;
  • Zhang, Lu-Yao (Shanghai Medical College of Fudan University) ;
  • Wang, Hong (Department of Hematology, The First Affiliated Hospital of Soochow University) ;
  • Yang, Bo (Fudan-Cinpathogen Clinical & Molecular Research Center) ;
  • Han, Tao (Fudan-Cinpathogen Clinical & Molecular Research Center) ;
  • Zhao, Xiao-Li (Department of Hematology, Huashan Hospital of Fudan University) ;
  • Wang, Wei (Department of Hematology, Huashan Hospital of Fudan University) ;
  • Wang, Xiao-Qin (Department of Hematology, Huashan Hospital of Fudan University) ;
  • Lin, Guo-Wei (Department of Hematology, Huashan Hospital of Fudan University)
  • Published : 2012.07.31
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Several potential risk factors have been identified for diffuse large B-cell lymphoma (DLBCL); however, epidemiological studies investigating the association between these risk factors and DLBCL have yielded inconsistent results. Objectives: To investigate potential medical, lifestyle, and environmental risk factors of DLBCL in Shanghai, China through a hospital-based case-control study. Method: One-hundred-and-forty-seven newly diagnosed DLBCL patients and 294 sex- and age-matched controls were recruited from 11 hospitals in Shanghai between 2003 and 2007. A standardized structured questionnaire was used to obtain patient data on demographics, medical history, family history, lifestyle, and environmental exposures. Conditional logistic regression models were used to estimate odds ratios (ORs), with 95% confidence intervals (CIs), for risk associated with each data category. Results: History of tuberculosis (TB) infection and "living on a farm" were positively associated with DLBCL (TB: OR=3.05, 95% CI: 1.19-7.80; farm: OR=1.82, 95% CI: 1.21-2.73). In contrast, taking traditional Chinese medicine was negatively associated with DLBCL (OR=0.36, 95% CI: 0.14-0.89). No significant correlation with DLBCL risk was found for any of the other potential risk factors (p>0.05), including but not limited to hair dyes, alcohol drinking, smoking, and home/workplace renovation within one year. Conclusions: Consistent with results from previous studies in other DLBCL case populations, traditional Chinese medicine appeared to have a direct or indirect protective effect against DLBCL. However, this study also identified a possible predisposition for DLBCL in TB sufferers and farmers.

Keywords

References

  1. Ameen R, Sajnani KP, Albassami A, Refaat S (2010). Frequencies of non-Hodgkin's lymphoma subtypes in Kuwait: comparisons between different ethnic groups. Ann Hematol, 89, 179-84. https://doi.org/10.1007/s00277-009-0801-z
  2. Askling J, Ekbom A (2001). Risk of non-Hodgkin's lymphoma following tuberculosis. Br J Cancer, 84, 113-5. https://doi.org/10.1054/bjoc.2000.1551
  3. Becker N, Deeg E, Nieters A (2004). Population-based study of lymphoma in Germany: rationale, study design and first results. Leuk Res, 28, 713-24. https://doi.org/10.1016/j.leukres.2003.11.010
  4. Bouvard V, Baan R, Straif K, et al (2009). A review of human carcinogens-Part B: biological agents. Lancet Oncol, 10, 321-2. https://doi.org/10.1016/S1470-2045(09)70096-8
  5. Chang ET, Smedby KE, Hjalgrim H, et al (2005). Medication use and risk of non-Hodgkin's lymphoma. Am J Epidemiol, 162, 965-74. https://doi.org/10.1093/aje/kwi311
  6. Chiu BCH, Weisenburger DD, Zahm SH, et al (2004). Agricultural pesticide use, familial cancer, and risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev, 13, 525-31.
  7. Ekstrom Smedby K, Vajdic CM, Falster M, et al (2008). Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood, 111, 4029-38. https://doi.org/10.1182/blood-2007-10-119974
  8. Eriksson M, Hardell L, Carlberg M, Akerman M (2008). Pesticide exposure as risk factor for non-Hodgkin lymphoma including histopathological subgroup analysis. Int J Cancer, 123, 1657-63. https://doi.org/10.1002/ijc.23589
  9. Fanourgiakis P, Mylona E, Androulakis, II, et al (2008). Non-Hodgkin's lymphoma and tuberculosis coexistence in the same organs: a report of two cases. Postgrad Med J, 84, 276-7. https://doi.org/10.1136/pgmj.2007.066183
  10. Figgs LW, Dosemeci M, Blair A (1995). United-States non-hodgkins-lymphoma surveillance by occupation 1984-1989 - a 24-state death certificate study. Am J Ind Med, 27, 817-35. https://doi.org/10.1002/ajim.4700270606
  11. Frankenfeld CL, Cerhan JR, Cozen W, et al (2008). Dietary flavonoid intake and non-Hodgkin lymphoma risk. Am J Clin Nutr, 87, 1439-45.
  12. Geyer SM, Morton LM, Habermann TM, et al (2010). Smoking, alcohol use, obesity, and overall survival from non-hodgkin lymphoma. Cancer, 116, 2993-3000. https://doi.org/10.1002/cncr.25114
  13. Harris NL, Jaffe ES, Diebold J, et al (2000). The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Mod Pathol, 13, 193-207. https://doi.org/10.1038/modpathol.3880035
  14. Hoffmann W, Terschueren C, Heimpel H, et al (2008). Population-based research on occupational and environmental factors for leukemia and non-Hodgkin's lymphoma: the Northern Germany Leukemia and Lymphoma Study (NLL). Am J Ind Med, 51, 246-57. https://doi.org/10.1002/ajim.20551
  15. Jiao J, Zheng T, Lan Q, et al (2012). Occupational solvent exposure, genetic variation of DNA repair genes, and the risk of non-Hodgkin's lymphoma. Eur J Cancer Prev.
  16. Kato I, Watanabe-Meserve H, Koenig KL, et al (2005). Pesticide product use and risk of non-Hodgkin lymphoma in women. Environ Health Perspect, 112, 1275-81.
  17. Keller-Byrne JE, Khuder SA, Schaub EA, McAfee O (1997). A meta-analysis of non-Hodgkin's lymphoma among farmers in the central United States. Am J Ind Med, 31, 442-4. https://doi.org/10.1002/(SICI)1097-0274(199704)31:4<442::AID-AJIM10>3.0.CO;2-#
  18. Khan AE, Gallo V, Linseisen J, et al (2008). Diabetes and the risk of non-Hodgkin's lymphoma and multiple myeloma in the European Prospective Investigation into Cancer and Nutrition. Haematologica, 93, 842-50. https://doi.org/10.3324/haematol.12297
  19. Kogevinas M, Becher H, Benn T, et al (1997). Cancer mortality in workers exposed to phenoxy herbicides, chlorophenols, and dioxins - An expanded and updated international cohort study. Am J Epidemiol, 145, 1061-75. https://doi.org/10.1093/oxfordjournals.aje.a009069
  20. McDuffie HH, Pahwa P, Spinelli JJ, et al (2002). Canadian male farm residents, pesticide safety handling practices, exposure to animals and non-Hodgkin's lymphoma (NHL). Am J Ind Med, 2, S54-61.
  21. Moller MB, Pedersen NT, Christensen BE (2004). Diffuse large B-cell lymphoma: clinical implications of extranodal versus nodal presentation - a population-based study of 1575 cases. Br J Haematol, 124, 151-9. https://doi.org/10.1046/j.1365-2141.2003.04749.x
  22. Monnereau A, Orsi L, Troussard X, et al (2008). Cigarette smoking, alcohol drinking, and risk of lymphoid neoplasms: results of a French case-control study. Cancer Causes Control, 19, 1147-60. https://doi.org/10.1007/s10552-008-9182-1
  23. Ohshima H, Bartsch H (1994). Chronic infections and inflammatory processes as cancer risk-factors - possible role of nitric-oxide in carcinogenesis. Mutat Res, 305, 253-64. https://doi.org/10.1016/0027-5107(94)90245-3
  24. Pearce N, Bethwaite P (1992). Increasing Incidence of Non-Hodgkin's Lymphoma: Occupational and Environmental Factors. Cancer Res, 52, S5496-500.
  25. Pearce N, McLean D (2005). Agricultural exposures and non-Hodgkin's lymphorna. Scand J Work Environ Health, 31, 18-25.
  26. Sangrajrang S, Renard H, Kuhaprema T, et al (2011). Personal Use of Hair Dyes - Increased Risk of Non-Hodgkin's Lymphoma in Thailand. Asian Pac J Cancer Prev, 12, 2393-6.
  27. Siegel R, Naishadham D, Jemal A (2012). Cancer statistics, 2012. CA Cancer J Clin, 62, 10-29. https://doi.org/10.3322/caac.20138
  28. Smedby KE, Hjalgrim H, Askling J, et al (2006). Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J Natl Cancer Inst, 98, 51-60. https://doi.org/10.1093/jnci/djj004
  29. Sonveaux P, Jordan BF, Gallez B, Feron O (2009). Nitric oxide delivery to cancer: Why and how? Eur J Cancer, 45, 1352-69. https://doi.org/10.1016/j.ejca.2008.12.018
  30. Talamini R, Polesel J, Montella M, et al (2005). Smoking and non-Hodgkin lymphoma: Case-control study in Italy. Int J Cancer, 115, 606-10. https://doi.org/10.1002/ijc.20891
  31. Talamini R, Polesel J, Spina M, et al (2008). The impact of tobacco smoking and alcohol drinking on survival of patients with non-Hodgkin lymphoma. Int J Cancer, 122, 1624-9.
  32. Tavani A, La Vecchia C, Franceschi S, et al (2000). Medical history and risk of Hodgkin's and non-Hodgkin's lymphomas. Eur J Cancer Prev, 9, 59-64. https://doi.org/10.1097/00008469-200002000-00008
  33. Tranah GJ, Bracci PM, Holly EA (2008). Domestic and farm-animal exposures and risk of non-Hodgkin's lymphoma in a population-based study in the San Francisco Bay Area. Cancer Epidemiol Biomarkers Prev, 17, 2382-7. https://doi.org/10.1158/1055-9965.EPI-08-0373
  34. Vineis P, Crosignani P, Sacerdote C, et al (2000). Haematopoietic cancer and medical history: a multicentre case control study. J Epidemiol Community Health, 54, 431-6. https://doi.org/10.1136/jech.54.6.431
  35. Wang XQ (2006). Cytogenetic study on 155 cases of non-Hodgkin' s lymphoma. Zhonghua Xue Ye Xue Za Zhi, 27, 656-60.
  36. Wu CY, Hu HY, Pu CY, et al (2011). Pulmonary tuberculosis increases the risk of lung cancer. Cancer, 117, 618-24. https://doi.org/10.1002/cncr.25616
  37. Yu YH, Liao CC, Hsu WH, et al (2011). Increased lung cancer risk among patients with pulmonary tuberculosis a population cohort study. J Thorac Oncol, 6, 32-7. https://doi.org/10.1097/JTO.0b013e3181fb4fcc
  38. Zahm SH, Blair A (1992). Pesticides and non-hodgkin's lymphoma. Cancer Res, 52, 5485-8.

Cited by

  1. Epirubicin Inhibits Soluble CD25 Secretion by Treg Cells Isolated from Diffuse Large B-cell Lymphoma Patients vol.14, pp.3, 2013, https://doi.org/10.7314/APJCP.2013.14.3.1721
  2. Type Distribution of Lymphomas in Lebanon: Five-Year Single Institution Experience vol.15, pp.14, 2014, https://doi.org/10.7314/APJCP.2014.15.14.5825
  3. PIK3CD promoted proliferation in diffuse large B cell lymphoma through upregulation of c-myc vol.37, pp.9, 2016, https://doi.org/10.1007/s13277-016-5225-5
  4. Epidemiologic characteristics of malignant lymphoma in Hubei, China vol.97, pp.35, 2018, https://doi.org/10.1097/MD.0000000000012120